# Safety and Tolerability Evaluation of PRO-230 Ophthalmic Solution

> **NCT05481489** · PHASE1 · WITHDRAWN · sponsor: **Laboratorios Sophia S.A de C.V.**

## Conditions studied

- Myopia

## Interventions

- **DRUG:** Atropine Sulfate

## Key facts

- **NCT ID:** NCT05481489
- **Lead sponsor:** Laboratorios Sophia S.A de C.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-02-01
- **Primary completion:** 2023-03-31
- **Final completion:** 2023-04-24
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Due to sponsors convenience.
- **Last updated:** 2024-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05481489

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05481489, "Safety and Tolerability Evaluation of PRO-230 Ophthalmic Solution". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05481489. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*